Fusen Pharmaceutical Balance Sheet Health
Financial Health criteria checks 1/6
Fusen Pharmaceutical has a total shareholder equity of CN¥562.2M and total debt of CN¥346.9M, which brings its debt-to-equity ratio to 61.7%. Its total assets and total liabilities are CN¥1.3B and CN¥781.5M respectively. Fusen Pharmaceutical's EBIT is CN¥21.5M making its interest coverage ratio 1.8. It has cash and short-term investments of CN¥34.8M.
Key information
61.7%
Debt to equity ratio
CN¥346.86m
Debt
Interest coverage ratio | 1.8x |
Cash | CN¥34.85m |
Equity | CN¥562.23m |
Total liabilities | CN¥781.52m |
Total assets | CN¥1.34b |
Recent financial health updates
Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky
May 21Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky
Dec 14Here's Why Fusen Pharmaceutical (HKG:1652) Can Manage Its Debt Responsibly
Sep 02Fusen Pharmaceutical (HKG:1652) Seems To Use Debt Quite Sensibly
Apr 02Does Fusen Pharmaceutical (HKG:1652) Have A Healthy Balance Sheet?
Dec 28Recent updates
Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky
May 21Fusen Pharmaceutical Company Limited's (HKG:1652) Popularity With Investors Under Threat As Stock Sinks 27%
Mar 31Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky
Dec 14Here's Why Fusen Pharmaceutical (HKG:1652) Can Manage Its Debt Responsibly
Sep 02Fusen Pharmaceutical (HKG:1652) Seems To Use Debt Quite Sensibly
Apr 02A Look At Fusen Pharmaceutical's (HKG:1652) Share Price Returns
Mar 06We Wouldn't Rely On Fusen Pharmaceutical's (HKG:1652) Statutory Earnings As A Guide
Feb 08Is Fusen Pharmaceutical Company Limited's (HKG:1652) Recent Price Movement Underpinned By Its Weak Fundamentals?
Jan 18Does Fusen Pharmaceutical (HKG:1652) Have A Healthy Balance Sheet?
Dec 28What You Need To Know About Fusen Pharmaceutical Company Limited's (HKG:1652) Investor Composition
Dec 07If You Had Bought Fusen Pharmaceutical (HKG:1652) Shares A Year Ago You'd Have Earned 34% Returns
Nov 20Financial Position Analysis
Short Term Liabilities: 1652's short term assets (CN¥566.8M) do not cover its short term liabilities (CN¥664.5M).
Long Term Liabilities: 1652's short term assets (CN¥566.8M) exceed its long term liabilities (CN¥117.0M).
Debt to Equity History and Analysis
Debt Level: 1652's net debt to equity ratio (55.5%) is considered high.
Reducing Debt: 1652's debt to equity ratio has increased from 30.8% to 61.7% over the past 5 years.
Debt Coverage: 1652's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 1652's interest payments on its debt are not well covered by EBIT (1.8x coverage).